Skip to main content
. 2017 May 18;12(5):e0177428. doi: 10.1371/journal.pone.0177428

Fig 1. Tumour take rates for both entities.

Fig 1

Tumour take rates for (a) HNSCC cell line FaDu and (b) human GBM cell line LN229 after injection of varying cell concentrations in PBS, undiluted MG (MGpure) or a 1:1 dilution of MG and PBS (MGdil). Depicted are the merged results of two and three injections of LN229 and FaDu, respectively, temporally separated by 4–8 weeks.